{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:21:31Z","timestamp":1777958491883,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T00:00:00Z","timestamp":1540857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100010293","name":"Seattle Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010293","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00520-018-4523-4","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T12:17:51Z","timestamp":1540901871000},"page":"2453-2462","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Patient-reported distress in Hodgkin lymphoma across the survivorship continuum"],"prefix":"10.1007","volume":"27","author":[{"given":"Jesse D.","family":"Troy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan C.","family":"Locke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg P.","family":"Samsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Feliciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshara","family":"Richhariya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W.","family":"LeBlanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,30]]},"reference":[{"key":"4523_CR1","unstructured":"SEER Cancer Statistics Review (1975-2014) National Cancer Institute, Bethesda, MD"},{"issue":"23","key":"4523_CR2","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1182\/blood-2014-05-579193","volume":"124","author":"AK Ng","year":"2014","unstructured":"Ng AK (2014) Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects. Blood 124(23):3373\u20133379. \n                    https:\/\/doi.org\/10.1182\/blood-2014-05-579193","journal-title":"Blood"},{"issue":"4","key":"4523_CR3","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/01.PSY.0000077503.96903.A6","volume":"65","author":"KW Brown","year":"2003","unstructured":"Brown KW, Levy AR, Rosberger Z, Edgar L (2003) Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychosom Med 65(4):636\u2013643","journal-title":"Psychosom Med"},{"key":"4523_CR4","unstructured":"Holland JC (2017) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Distress Management Version 2.2017. National Comprehensive Cancer Network, Inc. \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/distress.pdf\n                    \n                  . Accessed 8 Sept 2017"},{"issue":"1","key":"4523_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/1099-1611(200101\/02)10:1<19::AID-PON501>3.0.CO;2-6","volume":"10","author":"J Zabora","year":"2001","unstructured":"Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psycho-Oncology 10(1):19\u201328","journal-title":"Psycho-Oncology"},{"issue":"18","key":"4523_CR6","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1200\/JCO.2003.01.044","volume":"21","author":"PA Ganz","year":"2003","unstructured":"Ganz PA, Moinpour CM, Pauler DK, Kornblith AB, Gaynor ER, Balcerzak SP, Gatti GS, Erba HP, McCoy S, Press OW, Fisher RI (2003) Health status and quality of life in patients with early-stage Hodgkin\u2019s disease treated on southwest oncology group study 9133. J Clin Oncol 21(18):3512\u20133519. \n                    https:\/\/doi.org\/10.1200\/JCO.2003.01.044","journal-title":"J Clin Oncol"},{"issue":"7","key":"4523_CR7","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMoa1000067","volume":"363","author":"A Engert","year":"2010","unstructured":"Engert A, Plutschow A, Eich HT, Lohri A, Dorken B, Borchmann P, Berger B, Greil R, Willborn KC, Wilhelm M, Debus J, Eble MJ, Sokler M, Ho A, Rank A, Ganser A, Trumper L, Bokemeyer C, Kirchner H, Schubert J, Kral Z, Fuchs M, Muller-Hermelink HK, Muller RP, Diehl V (2010) Reduced treatment intensity in patients with early-stage Hodgkin\u2019s lymphoma. N Engl J Med 363(7):640\u2013652. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1000067","journal-title":"N Engl J Med"},{"issue":"5","key":"4523_CR8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1111961","volume":"366","author":"RM Meyer","year":"2012","unstructured":"Meyer RM, Gospodarowicz MK, Connors JM, Pearcey RG, Wells WA, Winter JN, Horning SJ, Dar AR, Shustik C, Stewart DA, Crump M, Djurfeldt MS, Chen BE, Shepherd LE, Group NCT, Eastern Cooperative Oncology G (2012) ABVD alone versus radiation-based therapy in limited-stage Hodgkin\u2019s lymphoma. N Engl J Med 366(5):399\u2013408. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1111961","journal-title":"N Engl J Med"},{"issue":"Suppl 5","key":"4523_CR9","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1093\/annonc\/9.suppl_5.S67","volume":"9","author":"V Diehl","year":"1998","unstructured":"Diehl V, Franklin J, Hasenclever D, Tesch H, Pfreundschuh M, Lathan B, Paulus U, Sieber M, Ruffer JU, Sextro M, Engert A, Wolf J, Hermann R, Holmer L, Stappert-Jahn U, Winnerlein-Trump E, Wulf G, Krause S, Glunz A, von Kalle K, Bischoff H, Haedicke C, Duhmke E, Georgii A, Loeffler M (1998) BEACOPP: a new regimen for advanced Hodgkin\u2019s disease. German Hodgkin\u2019s Lymphoma Study. Group Ann Oncol 9(Suppl 5):S67\u2013S71","journal-title":"Group Ann Oncol"},{"issue":"6","key":"4523_CR10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1200\/JCO.2012.43.4803","volume":"31","author":"LI Gordon","year":"2013","unstructured":"Gordon LI, Hong F, Fisher RI, Bartlett NL, Connors JM, Gascoyne RD, Wagner H, Stiff PJ, Cheson BD, Gospodarowicz M, Advani R, Kahl BS, Friedberg JW, Blum KA, Habermann TM, Tuscano JM, Hoppe RT, Horning SJ (2013) Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the eastern cooperative oncology group (E2496). J Clin Oncol 31(6):684\u2013691. \n                    https:\/\/doi.org\/10.1200\/JCO.2012.43.4803","journal-title":"J Clin Oncol"},{"issue":"18","key":"4523_CR11","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1200\/JCO.2011.38.0410","volume":"30","author":"A Younes","year":"2012","unstructured":"Younes A, Gopal AK, Smith SE, Ansell SM, Rosenblatt JD, Savage KJ, Ramchandren R, Bartlett NL, Cheson BD, de Vos S, Forero-Torres A, Moskowitz CH, Connors JM, Engert A, Larsen EK, Kennedy DA, Sievers EL, Chen R (2012) Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin\u2019s lymphoma. J Clin Oncol 30(18):2183\u20132189. \n                    https:\/\/doi.org\/10.1200\/JCO.2011.38.0410","journal-title":"J Clin Oncol"},{"issue":"13","key":"4523_CR12","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S1470-2045(13)70501-1","volume":"14","author":"A Younes","year":"2013","unstructured":"Younes A, Connors JM, Park SI, Fanale M, O'Meara MM, Hunder NN, Huebner D, Ansell SM (2013) Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin\u2019s lymphoma: a phase 1, open-label, dose-escalation study. Lancet Oncol 14(13):1348\u20131356. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(13)70501-1","journal-title":"Lancet Oncol"},{"issue":"suppl; abstr 10","key":"4523_CR13","doi-asserted-by":"publisher","first-page":"10009","DOI":"10.1200\/JCO.2017.35.15_suppl.10009","volume":"35","author":"H Singh","year":"2017","unstructured":"Singh H, Kanapuru B, Smith C, Fashoyin-Aje LA, Myers A, Kim G, Pazdur R (2017) FDA analysis of enrollment of older adults in clinical trials for cancer drug registration: a 10-year experience by the U.S. Food and Drug Administration. J Clin Oncol 35(suppl; abstr 10009):10009","journal-title":"J Clin Oncol"},{"issue":"12","key":"4523_CR14","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1007\/s00520-014-2290-4","volume":"22","author":"CK Fang","year":"2014","unstructured":"Fang CK, Chang MC, Chen PJ, Lin CC, Chen GS, Lin J, Hsieh RK, Chang YF, Chen HW, Wu CL, Lin KC, Chiu YJ, Li YC (2014) A correlational study of suicidal ideation with psychological distress, depression, and demoralization in patients with cancer. Support Care Cancer 22(12):3165\u20133174. \n                    https:\/\/doi.org\/10.1007\/s00520-014-2290-4","journal-title":"Support Care Cancer"},{"issue":"26","key":"4523_CR15","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1200\/JCO.2008.19.9463","volume":"27","author":"A Hurria","year":"2009","unstructured":"Hurria A, Li D, Hansen K, Patil S, Gupta R, Nelson C, Lichtman SM, Tew WP, Hamlin P, Zuckerman E, Gardes J, Limaye S, Lachs M, Kelly E (2009) Distress in older patients with cancer. J Clin Oncol 27(26):4346\u20134351. \n                    https:\/\/doi.org\/10.1200\/jco.2008.19.9463","journal-title":"J Clin Oncol"},{"issue":"7","key":"4523_CR16","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1002\/pon.3170","volume":"22","author":"Y Wang","year":"2013","unstructured":"Wang Y, Zou L, Jiang M, Wei Y, Jiang Y (2013) Measurement of distress in Chinese inpatients with lymphoma. Psycho-Oncology 22(7):1581\u20131586. \n                    https:\/\/doi.org\/10.1002\/pon.3170","journal-title":"Psycho-Oncology"},{"issue":"7","key":"4523_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/pon.993","volume":"15","author":"S Ransom","year":"2006","unstructured":"Ransom S, Jacobsen PB, Booth-Jones M (2006) Validation of the distress thermometer with bone marrow transplant patients. Psycho-Oncology 15(7):604\u2013612. \n                    https:\/\/doi.org\/10.1002\/pon.993","journal-title":"Psycho-Oncology"},{"key":"4523_CR18","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S1470-2045(16)30093-6","volume":"17","author":"S Kreissl","year":"2016","unstructured":"Kreissl S, Mueller H, Goergen H, Mayer A, Brillant C, Behringer K, Halbsguth TV, Hitz F, Soekler M, Shonukan O, Rueffer JU, Flechtner HH, Fuchs M, Diehl V, Engert A, Borchmann P (2016) Cancer-related fatigue in patients with and survivors of Hodgkin\u2019s lymphoma: a longitudinal study of the German Hodgkin study group. Lancet Oncol 17:1453\u20131462. \n                    https:\/\/doi.org\/10.1016\/s1470-2045(16)30093-6","journal-title":"Lancet Oncol"},{"issue":"12","key":"4523_CR19","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S1470-2045(09)70258-X","volume":"10","author":"N Heutte","year":"2009","unstructured":"Heutte N, Flechtner HH, Mounier N, Mellink WA, Meerwaldt JH, Eghbali H, van\u2019t Veer MB, Noordijk EM, Kluin-Nelemans JC, Lampka E, Thomas J, Lugtenburg PJ, Viterbo L, Carde P, Hagenbeek A, van der Maazen RW, Smit WG, Brice P, van Marwijk Kooy M, Baars JW, Poortmans P, Tirelli U, Leeksma OC, Tomsic R, Feugier P, Salles G, Gabarre J, Kersten MJ, Van Den Neste E, Creemers GJ, Gaillard I, Meijnders P, Tertian G, Reman O, Muller HP, Troncy J, Blanc M, Schroyens W, Voogt PJ, Wijermans P, Rieux C, Ferme C, Henry-Amar M, Group E-GHT (2009) Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial. Lancet Oncol 10(12):1160\u20131170. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(09)70258-X","journal-title":"Lancet Oncol"},{"issue":"18","key":"4523_CR20","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1200\/JCO.2016.72.1373","volume":"35","author":"L Nekhlyudov","year":"2017","unstructured":"Nekhlyudov L, Ganz PA, Arora NK, Rowland JH (2017) Going beyond being lost in transition: a decade of progress in cancer survivorship. J Clin Oncol 35(18):1978\u20131981. \n                    https:\/\/doi.org\/10.1200\/JCO.2016.72.1373","journal-title":"J Clin Oncol"},{"issue":"2","key":"4523_CR21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.6004\/jnccn.2013.0027","volume":"11","author":"JC Holland","year":"2013","unstructured":"Holland JC, Andersen B, Breitbart WS, Buchmann LO, Compas B, Deshields TL, Dudley MM, Fleishman S, Fulcher CD, Greenberg DB, Greiner CB, Handzo GF, Hoofring L, Hoover C, Jacobsen PB, Kvale E, Levy MH, Loscalzo MJ, McAllister-Black R, Mechanic KY, Palesh O, Pazar JP, Riba MB, Roper K, Valentine AD, Wagner LI, Zevon MA, McMillian NR, Freedman-Cass DA (2013) Distress management. J Natl Compr Cancer Netw 11(2):190\u2013209","journal-title":"J Natl Compr Cancer Netw"},{"issue":"2","key":"4523_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377\u2013381. \n                    https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"issue":"7","key":"4523_CR23","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00520-014-2143-1","volume":"22","author":"X Ma","year":"2014","unstructured":"Ma X, Zhang J, Zhong W, Shu C, Wang F, Wen J, Zhou M, Sang Y, Jiang Y, Liu L (2014) The diagnostic role of a short screening tool\u2014the distress thermometer: a meta-analysis. Support Care Cancer 22(7):1741\u20131755. \n                    https:\/\/doi.org\/10.1007\/s00520-014-2143-1","journal-title":"Support Care Cancer"},{"issue":"27","key":"4523_CR24","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059\u20133068. \n                    https:\/\/doi.org\/10.1200\/jco.2013.54.8800","journal-title":"J Clin Oncol"},{"issue":"6","key":"4523_CR25","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1177\/1740774516655101","volume":"13","author":"PJ Atherton","year":"2016","unstructured":"Atherton PJ, Burger KN, Pederson LD, Kaggal S, Sloan JA (2016) Patient-reported outcomes questionnaire compliance in Cancer Cooperative Group Trials (Alliance N0992). Clin Trials 13(6):612\u2013620. \n                    https:\/\/doi.org\/10.1177\/1740774516655101","journal-title":"Clin Trials"},{"issue":"Suppl 1","key":"4523_CR26","doi-asserted-by":"publisher","first-page":"i66","DOI":"10.1093\/annonc\/mdw080","volume":"27","author":"M Friedlander","year":"2016","unstructured":"Friedlander M, Mercieca-Bebber RL, King MT (2016) Patient-reported outcomes (PRO) in ovarian cancer clinical trials-lost opportunities and lessons learned. Ann Oncol 27(Suppl 1):i66\u2013i71. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdw080","journal-title":"Ann Oncol"},{"issue":"5","key":"4523_CR27","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/pon.1425","volume":"18","author":"S Bauwens","year":"2009","unstructured":"Bauwens S, Baillon C, Distelmans W, Theuns P (2009) The \u2018Distress Barometer\u2019: validation of method of combining the distress thermometer with a rated complaint scale. Psycho-Oncology 18(5):534\u2013542. \n                    https:\/\/doi.org\/10.1002\/pon.1425","journal-title":"Psycho-Oncology"},{"issue":"3","key":"4523_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00277-013-1881-3","volume":"93","author":"N Vermaete","year":"2014","unstructured":"Vermaete N, Wolter P, Verhoef G, Gosselink R (2014) Physical activity and physical fitness in lymphoma patients before, during, and after chemotherapy: a prospective longitudinal study. Ann Hematol 93(3):411\u2013424. \n                    https:\/\/doi.org\/10.1007\/s00277-013-1881-3","journal-title":"Ann Hematol"},{"issue":"8","key":"4523_CR29","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"JS Temel","year":"2010","unstructured":"Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733\u2013742. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1000678","journal-title":"N Engl J Med"},{"issue":"9930","key":"4523_CR30","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S0140-6736(13)62416-2","volume":"383","author":"C Zimmermann","year":"2014","unstructured":"Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, Moore M, Rydall A, Rodin G, Tannock I, Donner A, Lo C (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383(9930):1721\u20131730. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(13)62416-2","journal-title":"Lancet"},{"issue":"7","key":"4523_CR31","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/jama.2009.1198","volume":"302","author":"M Bakitas","year":"2009","unstructured":"Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J, Hull JG, Li Z, Tosteson TD, Byock IR, Ahles TA (2009) Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the project ENABLE II randomized controlled trial. JAMA 302(7):741\u2013749. \n                    https:\/\/doi.org\/10.1001\/jama.2009.1198","journal-title":"JAMA"},{"issue":"13","key":"4523_CR32","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1200\/JCO.2014.58.6362","volume":"33","author":"MA Bakitas","year":"2015","unstructured":"Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z, Dionne-Odom JN, Frost J, Dragnev KH, Hegel MT, Azuero A, Ahles TA (2015) Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol 33(13):1438\u20131445. \n                    https:\/\/doi.org\/10.1200\/JCO.2014.58.6362","journal-title":"J Clin Oncol"},{"issue":"20","key":"4523_CR33","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1001\/jama.2016.16786","volume":"316","author":"A El-Jawahri","year":"2016","unstructured":"El-Jawahri A, LeBlanc T, VanDusen H, Traeger L, Greer JA, Pirl WF, Jackson VA, Telles J, Rhodes A, Spitzer TR, McAfee S, Chen YA, Lee SS, Temel JS (2016) Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial. JAMA 316(20):2094\u20132103. \n                    https:\/\/doi.org\/10.1001\/jama.2016.16786","journal-title":"JAMA"},{"issue":"4","key":"4523_CR34","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/bjc.2013.779","volume":"110","author":"LA Daniels","year":"2014","unstructured":"Daniels LA, Oerlemans S, Krol AD, Creutzberg CL, van de Poll-Franse LV (2014) Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity. Br J Cancer 110(4):868\u2013874. \n                    https:\/\/doi.org\/10.1038\/bjc.2013.779","journal-title":"Br J Cancer"},{"issue":"32","key":"4523_CR35","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1200\/JCO.2017.73.2800","volume":"35","author":"A El-Jawahri","year":"2017","unstructured":"El-Jawahri A, Traeger L, Greer JA, VanDusen H, Fishman SR, LeBlanc TW, Pirl WF, Jackson VA, Telles J, Rhodes A, Li Z, Spitzer TR, McAfee S, Chen YA, Temel JS (2017) Effect of inpatient palliative care during hematopoietic stem-cell transplant on psychological distress 6 months after transplant: results of a randomized clinical trial. J Clin Oncol 35(32):3714\u20133721. \n                    https:\/\/doi.org\/10.1200\/JCO.2017.73.2800","journal-title":"J Clin Oncol"},{"issue":"3","key":"4523_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1200\/JCO.2013.53.1194","volume":"32","author":"GP Canellos","year":"2014","unstructured":"Canellos GP, Rosenberg SA, Friedberg JW, Lister TA, Devita VT (2014) Treatment of Hodgkin lymphoma: a 50-year perspective. J Clin Oncol 32(3):163\u2013168. \n                    https:\/\/doi.org\/10.1200\/JCO.2013.53.1194","journal-title":"J Clin Oncol"},{"issue":"1","key":"4523_CR37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12955-016-0515-6","volume":"14","author":"N Linendoll","year":"2016","unstructured":"Linendoll N, Saunders T, Burns R, Nyce JD, Wendell KB, Evens AM, Parsons SK (2016) Health-related quality of life in Hodgkin lymphoma: a systematic review. Health Qual Life Outcomes 14(1):114. \n                    https:\/\/doi.org\/10.1186\/s12955-016-0515-6","journal-title":"Health Qual Life Outcomes"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4523-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-018-4523-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4523-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T17:18:49Z","timestamp":1572455929000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-018-4523-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,30]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["4523"],"URL":"https:\/\/doi.org\/10.1007\/s00520-018-4523-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,30]]},"assertion":[{"value":"11 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jesse Troy reports honoraria from GamidaCell, consulting fees from The EMMES Corporation, AegisCN, and The Community Data Roundtable; Thomas LeBlanc reports consulting fees from Amgen, Agios, AbbVie, CareVive, Celgene, Pfizer, Helsinn, Flatiron Health, Medtronic, Otsuka, Welvie, and Heron, grants from American Cancer Society, AstraZeneca, and Cambia Health Solutions. Jose Feliciano and Akshara Richhariya report equity ownership and employment at Seattle Genetics. Susan Locke and Greg Samsa have no disclosures to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}